台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    98.8
  • 漲跌
    ▲1.5
  • 漲幅
    +1.54%
  • 成交量
    677
  • 產業
    上櫃 生技醫療類股
  • 309人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
智擎 (4162)籌碼相關-第一金-大稻埕 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0402/1602/2603/1003/2004/0104/039095100105110115120125May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

第一金-大稻埕 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/021.599.1300.0098.801.51,7700.08%
2025/03/31397.57196.9096.2021,7710.11%
2025/03/288100.941100.50100.5071,7520.40%
2025/03/2700.001103.00103.50-11,728-0.06%
2025/03/212107.500106.00106.5021,7140.12%
2025/03/200106.2500.00106.0001,7130.00%
2025/03/1700.001105.50105.00-11,714-0.06%
2025/03/111105.001105.00107.0001,6970.00%
2025/03/076106.7500.00107.5061,6650.36%
2025/03/061112.0000.00111.0011,6470.06%
2025/03/051115.0000.00115.5011,6450.06%
2025/03/043112.5000.00114.5031,6340.18%
2025/03/0300.004113.13112.50-41,620-0.25%
2025/02/274111.504109.25109.0001,5680.00%
2025/02/2600.003119.67115.50-31,553-0.19%
2025/02/2500.001113.00113.00-11,443-0.07%
2025/02/191110.0000.00110.0011,3960.07%
2025/02/141110.0000.00111.5011,4080.07%
2025/02/131110.0000.00111.5011,4130.07%
2025/02/114112.251110.50109.0031,3920.22%
2025/02/071117.0000.00120.5011,3510.07%
2025/02/062119.001.9119.39119.000.11,3290.01%
2025/02/0500.001.8112.42113.00-1.81,194-0.15%
2025/02/0400.003102.00103.00-31,201-0.25%
2025/01/100.196.1500.0097.000.11,3550.00%
2025/01/0800.001101.50103.00-11,299-0.08%
2025/01/0600.001100.00101.50-11,259-0.08%
2025/01/03198.3000.0098.3011,2400.08%
2025/01/02194.4000.0093.6011,2350.08%
2024/12/2600.00193.5092.50-11,225-0.08%
2024/12/05095.2000.0094.6001,1700.00%
2024/12/030.194.9700.0094.400.11,1610.01%
2024/12/020.194.8000.0094.400.11,1580.01%
2024/11/1100.006103.50103.50-6882-0.68%
2024/11/056106.0000.00106.0067820.77%
2024/11/010.1108.0000.00105.000.17300.01%
2024/10/242100.00398.1098.30-1494-0.20%
2024/10/23188.00692.9093.70-5424-1.18%
2024/10/18288.2000.0086.8024500.44%
2024/10/15190.2000.0090.2014830.21%
2024/10/11288.3000.0088.3025020.40%
2024/09/27187.8000.0087.8015560.18%
2024/09/2000.00888.5087.40-8644-1.24%
2024/08/14384.0000.0083.6037550.40%
2024/08/12184.2000.0084.9017800.13%
2024/08/05384.0000.0083.0037640.39%
2024/07/22293.40192.6092.0017180.14%
2024/07/1900.00296.8094.20-2708-0.28%
2024/07/17097.9000.0098.2006580.00%
2024/07/16097.70198.2097.00-1658-0.15%
2024/07/152.196.78199.0098.401.16630.16%
2024/07/11096.0000.0095.2006500.00%
2024/07/10096.7900.0096.6006580.00%
2024/07/093.1101.45498.8096.30-0.9668-0.14%
2024/07/0800.001100.00100.50-1655-0.15%
2024/07/05296.9500.0097.5026250.32%
2024/07/0300.00696.9396.70-6628-0.95%
2024/07/02699.57898.7697.80-2623-0.32%
2024/07/011099.507100.19101.0036100.49%
2024/06/28396.80597.0497.50-2581-0.34%
2024/06/27497.78495.9095.7005820.00%
2024/06/26796.59296.9597.6055760.87%
2024/06/25194.00193.2094.3005680.00%
2024/06/1900.00193.7093.80-1637-0.16%
2024/06/17195.90196.2095.5006440.00%
2024/06/1400.00195.6095.30-1655-0.15%
2024/06/1300.00196.8096.90-1651-0.15%
2024/06/0600.00292.1091.10-2630-0.32%
2024/06/05190.9000.0092.9016320.16%
2024/06/04291.1500.0090.8026470.31%
2024/06/03190.7000.0090.7016930.14%
2024/05/27192.0000.0091.7017760.13%
2024/05/24292.8000.0092.8028080.25%
2024/05/2300.00294.4093.60-2842-0.24%
2024/05/2200.00294.7094.10-2847-0.24%
2024/05/21297.20296.7095.1008500.00%
2024/05/17497.88198.5097.9038720.34%
2024/04/24190.8000.0090.7011,4550.07%
2024/04/18193.5000.0093.6011,5250.07%
2024/04/17192.5000.0092.6011,5410.06%
2024/04/16192.70691.2091.00-51,557-0.32%
2024/04/10098.2000.0098.8001,6420.00%
2024/04/080.199.8500.0099.100.11,7700.00%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-2025/03/03
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章
 
 
218小時54